Project Grant R21DE034956
Award Date
4/1/25
Completion Date
3/31/27
Dollars Obligated
$235K
Federal Agency
National Institute of Dental and Craniofacial Research
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This $229,440 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to investigate the mechanistic basis for differential responses to radio-immunotherapy in head and neck squamous cell carcinoma (HNSCC) and pancreatic ductal adenocarcinoma (PDAC). The research aims to elucidate how the tumor microenvironment, particularly the role of regulatory T cells (Tregs), impacts...
This $434,170 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports the development and evaluation of a novel engineered bacterial in situ vaccination platform for oral cancer immunotherapy. The key products and services to be delivered under this award include: Development of potent and programmable non-pathogenic E. coli bacteria that can be biomaterial-encapsulated to...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under CFDA Program 93.121 Oral Diseases and Disorders Research, provides $556,548.00 to Emory University to develop an artificial intelligence-driven system for online adaptive and personalized proton therapy (AID-ON-APPT). The proposed system aims to enable real-time adaptive planning for proton radiation therapy, accounting for anatomical changes during the treatment course to improve...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $645,949 to Emory University to conduct research that aims to understand how the protein SAMHD1 governs radiation and immunological dynamics in breast cancer, particularly triple-negative breast cancer (TNBC). The goal is to determine the molecular mechanisms by which SAMHD1 suppresses the immune response and reduces the efficacy of immune checkpoint inhibitors (ICI) and ionizing...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) totaling $662,516 aims to investigate how fractionated radiation affects the tumor microenvironment to enhance drug delivery and improve the safety and efficacy of chemoradiotherapy for locally advanced head and neck squamous cell carcinoma and anaplastic thyroid cancer. The key research objectives include: 1) Quantifying how local radiation reshapes the tumor microenvironment to influence...
This $170,208 Project Grant award was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant will fund a 4-year career development plan for Dr. R. Alex Harbison to become an independent physician-scientist focused on using "polyamine blockade therapy" to enhance immune responses against head and neck squamous cell carcinoma. The research aims to define the mechanisms by which...
This $390,000 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under its Oral Diseases and Disorders Research program (CFDA 93.121), supports research to leverage single-cell co-culture and gene expression profiling to identify tumor antigen-specific T cells in oral squamous cell carcinoma (OSCC). The key products and services to be delivered include: Optimizing a high-throughput, single-cell co-culture system to isolate individual tumor-killing T...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $204,688 to The Johns Hopkins University to develop novel immunotherapies for HPV-associated head and neck cancers. The research focuses on three key products: 1) Salmonella-derived nanoparticles (SOMV-9RE7) to effectively stimulate the immune system, 2) Albumin-fused cytokines (ALB-FLT3L and ALB-IFNB) to expand...
This $198,750 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports research to characterize and mitigate radiation-induced pain and oral mucositis in head and neck cancer patients. The key products and services to be delivered under this 2-year award include: 1) in vivo and in vitro evaluation of radiation-induced changes to sensory nerve density and nociceptive behavior in an...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research federal grant program (CFDA 93.121), will provide $701,699 to The General Hospital Corporation (Massachusetts General Hospital) to conduct research on the spatial regulators of the hybrid epithelial/mesenchymal state and its impact on immune infiltration in head and neck squamous cell carcinoma. The research will: 1) further define the effect of this...